A. Iida

发表

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Tadashi Kaname, Hiroshi Kawaguchi, Ryozo Nagai, 1997, Nature.

IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats

D. Lubarsky, A. Iida, H. Yi, 2017, Gene Therapy.

Pseudotyped Lentivirus Vectors Derived from Simian Immunodeficiency Virus SIVagm with Envelope Glycoproteins from Paramyxovirus

Y. Ueda, M. Hasegawa, A. Iida, 2003, Journal of Virology.

Improvement of multiple pathophysiological phenotypes of klotho (kl/kl) mice by adenovirus‐mediated expression of the klotho gene

M. Noda, M. Kuro-o, H. Anazawa, 2000, The journal of gene medicine.

Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein

M. Hasegawa, E. Alton, A. Iida, 2007, Gene Therapy.

Sendai virus-mediated CFTR gene transfer to the airway epithelium

A. M. Wright, D. Geddes, B. Wainwright, 2007, Gene Therapy.

In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome.

R. Nagai, Toru Suzuki, M. Kurabayashi, 2000, Biochemical and biophysical research communications.

CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector

A. Mehta, P. Hegyi, Z. Rakonczay, 2008 .

Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

I. Chen, K. Fukuda, M. Hasegawa, 2013, Cellular reprogramming.

Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system

J. Yee, T. Friedmann, A. Iida, 1996, Journal of virology.

Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein 1

M. Kuro-o, H. Anazawa, Y. Matsumura, 1998, FEBS letters.

Nontransmissible Virus-Like Particle Formation by F-Deficient Sendai Virus Is Temperature Sensitive and Reduced by Mutations in M and HN Proteins

T. Tokusumi, Y. Nagai, M. Hasegawa, 2003, Journal of Virology.

A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression

T. Hirata, Y. Nagai, Y. Ueda, 2000, Journal of Virology.

A Novel Protective MHC-I Haplotype Not Associated with Dominant Gag-Specific CD8+ T-Cell Responses in SIVmac239 Infection of Burmese Rhesus Macaques

A. Kimura, M. Hasegawa, Y. Koyanagi, 2013, PloS one.

Cytotoxic T Lymphocyte–based Control of Simian Immunodeficiency Virus Replication in a Preclinical AIDS Vaccine Trial

Takahiro Hirata, Akiko Takeda, Chie Sugimoto, 2004, The Journal of experimental medicine.

Impact of Vaccination on Cytotoxic T Lymphocyte Immunodominance and Cooperation against Simian Immunodeficiency Virus Replication in Rhesus Macaques

A. Kimura, M. Hasegawa, A. Iida, 2011, Journal of Virology.

A new serine protease family with elastase activity is produced by Streptomyces bacteria.

A. Iida, S. Etoh, Akinori Mimura, 2020, Microbiology.

Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells

S. Tsujitani, Y. Yonemitsu, Y. Ueda, 2011, Scientific reports.

Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system.

J. Yee, T. Friedmann, Shin-Tai Chen, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Concept and Technology Underlying Sendai Virus (SeV) Vector Development

A. Iida, M. Inoue, 2013 .

Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties

Y. Nagai, M. Hasegawa, A. Iida, 2004, The journal of gene medicine.

Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases

Y. Nagai, M. Hasegawa, A. Iida, 2004, Gene Therapy.

A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading

T. Tokusumi, Y. Nagai, M. Hasegawa, 2003, Journal of Virology.

An improved method for recovery of F-defective Sendai virus expressing foreign genes from cloned cDNA.

Y. Nagai, M. Hasegawa, A. Kato, 2002, Journal of virological methods.

Cytoplasmic RNA vector derived from nontransmissible Sendai virus. Production and use.

M. Hasegawa, A. Iida, 2002, Methods in molecular medicine.

Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques.

M. Hasegawa, A. Iida, T. Matano, 2008, Vaccine.

Amplification of protein expression in a cell free system.

S. Hecht, A. Iida, E. Resto, 1992, Nucleic acids research.

[Sendai virus vector: vector development and its application to health care and biotechnology].

A. Iida, 2007, Uirusu.

Recombinant Sendai viruses expressing different levels of a foreign reporter gene.

T. Tokusumi, Y. Nagai, M. Hasegawa, 2002, Virus research.

Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences.

Y. Nagai, M. Hasegawa, A. Iida, 2008, Microbes and infection.

[Development of Sendai virus vectors and their application to the fields of medical care and biotechnology].

A. Iida, 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

Protective Efficacy of an AIDS Vaccine, a Single DNA Priming Followed by a Single Booster with a Recombinant Replication-Defective Sendai Virus Vector, in a Macaque AIDS Model

Y. Nagai, M. Hasegawa, A. Iida, 2003, Journal of Virology.

Naked Sendai virus vector lacking all of the envelope‐related genes: reduced cytopathogenicity and immunogenicity

Y. Nagai, M. Hasegawa, H. Iwasaki, 2006, The journal of gene medicine.

Cytokine-Based Log-Scale Expansion of Functional Murine Dendritic Cells

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2009, PloS one.

Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus.

E. Higashihara, S. Horie, Y. Nagai, 2005, Vaccine.

Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies.

M. Hasegawa, A. Iida, T. Matano, 2011, Vaccine.

Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.

A. Kimura, M. Hasegawa, T. Kuwano, 2011, Biochemical and biophysical research communications.